Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,171.90
(
0.50%
)
US TECH 100
26,538.40
(
0.29%
)
Dow Jones
49,520.14
(
1.35%
)
Brent Oil
109.34
(
-2.71%
)
Bitcoin
76,080.42
(
0.40%
)
News Focus
News Focus
Post# of 257471
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122912
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: dewophile post# 247603

Wednesday, 07/17/2024 1:58:01 PM

Wednesday, July 17, 2024 1:58:01 PM

Post# of 257471
Re: IRA drug-price “negotiations”

JNJ said on today’s 2Q24 CC that there were no unpleasant surprises on the IRA price negotiations for Stelara and Xarelto, two of the 10 drugs subject to 2026 price negotiation.

BMY, part-owner (with PFE) of Eliquis—the largest-selling drug subject to 2026 IRA price negotiation—is +5% today.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today